Tribe Capital Growth Corp I Notified of Loan Agreement in Recent 8-K Filing

On December 13, 2024, Tribe Capital Growth Corp I, also known as Iris Acquisition Corp, received notification regarding a loan agreement involving Hannah Immunotheraputics, LLC. The loan, amounting to approximately $1.12 million, was agreed upon to facilitate the acquisition of the former managing member of the Company’s sponsor, Iris Acquisition Holdings, LLC. This agreement was reached on July 24, 2024.

The loan facilitated the acquisition process, resulting in the former managing member, Columbass Limited, resigning from their position as managing member of the Sponsor on October 30, 2024. Following this, Iris Equity Holdings LLC assumed the role of managing member of the Sponsor. The repayment of the principal and interest on the loan is in progress and is expected to be completed soon.

Chris Kim, the Chief Executive Officer of Liminatus Pharma, LLC, is affiliated with Hannah Immunotheraputics, LLC, the entity providing the loan. It is clarified in the filing that Mr. Kim has no associations or relationships with Tribe Capital Growth Corp I, its sponsor’s members, including the former and new managing members, or the buyer involved in the acquisition.

This strategic financial move, as reported in the 8-K filing, highlights an important transaction that occurred within the company. The details provided shed light on the financial intricacies and changes within Tribe Capital Growth Corp I.

For further updates and financial developments, interested parties can refer to the official SEC filings and statements released by the company. The article serves to inform readers and stakeholders about the recent financial event within the company.

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Tribe Capital Growth Corp I’s 8K filing here.

About Tribe Capital Growth Corp I

Tribe Capital Growth Corp I does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in San Francisco, California.